A subset analysis of diabetic patients in the SPIRIT II Clinical trial of the XIENCE V Everolimus Eluting Stent System ...
Agfa HealthCare has signed a multi-million dollar deal with Thomas Memorial Hospital in South Charleston, WV and will ...
Early clinical results from Abbott's ongoing ABSORB clinical trial, the world's first study to evaluate the safety and performance of a fully bioabsorbable drug-eluting stent platform for the treatment of coronary artery disease in humans, were presented during the 18th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
Cardium Therapeutics and its subsidiary InnerCool Therapies reported on preclinical data demonstrating a new and ...
Boston Scientific Corporation announced that an independent meta-analysis of more than 3,500 patients from five clinical ...
A stent designed to dissolve after it completes its task of propping open narrowed heart arteries is being tested by scientists. The first human experiment with the dissolving stent is being conducted with 26 patients at hospitals in New Zealand and Europe, the Associated Press reported. The study is designed to test whether the stent is safe enough to be used in larger studies.
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
ev3 Inc. has announced a worldwide fracture-free guarantee in support of its new EverFlex family of stents. In the event ...
GlaxoSmithKline and Flamel Technologies announced FDA approval of once-a-day Coreg CR (carvedilol phosphate) extended ...
When it comes to opening blocked carotid arteries, surgery may be less risky than stents according to a study by French doctors including Jean-Louis Mas, M.D., of the Hospitaux Sainte-Anne in Paris.
Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the ...
Obesity and the illnesses associated with it cost the U.S. some 90.7 billion dollars a year in health care costs, a University of Pennsylvania researcher said. Among developed countries, the U.S. has the most obese and overweight people, representing 66 percent of its overall population.
A new program designed to provide hospitals with practical tools to help them reduce door-to-balloon times in STEMI ...
Radiofrequency ablation is more effective than treatment with amiodarone for the prevention of atrial flutter recurrence in patients who experienced a first symptomatic episode, according to the results of a new study. In addition to the superiority of ablation over amiodarone, there was no increased risk of atrial fibrillation, even in this cohort of older patients, report investigators.
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
CoreValve announced that its patented ReValving System, consisting of a 18F delivery catheter, was used to percutaneously implant its proprietary porcine pericardial-tissue bioprosthesis over the severely calcified aortic heart valve of an 89-year-old woman.
A test designed to measure the durability of CoreValve’s ReValving device reached 200 million cycles, the company has reported. CoreValve’s chairman, CEO and founder, Dr. Jacques Seguin, says initial findings indicate its proprietary porcine pericardium aortic heart valve behaves, in vitro, better than tissue valves.
First U.S. installations of Volcano Corp.’s s5i IVUS (intravascular ultrasound) imaging system have been completed at ...